Medicare’s Unprecedented Alzheimer’s Drug Decision
Last week, Medicare took an unprecedented step to restrict patients’ access to the first new treatment for Alzheimer’s disease in nearly 20 years. We talk with a doctor, a patient and a former federal official about this unusual move and its potentially wide-ranging implications.